Replies to post #329171 on Bioelectronics Corp (BIEL)

[GetSeriousOK]

Sub-penny pinkies get manipulated all the time. I'm confident I'll be able to sell at .0002 or .0003 eventually.... unless they do the R/S which is going to be catastrophic so I'm watching their Maryland corporation page like a hawk. They will file an amendment there before they implement the R/S.

The bagholders will jeer and call me a "flipper" which will make me laugh all the way to the bank.

Management won't pull the plug. There is NO WAY the Whelans and Staelin walk away from their money. They'll do a reverse split. Multiple reverse splits, probably, to coincide with the maturity of their convertible loans.

They will need press releases though. Reinstating the patents would be a big event, IMO. Publication of Ilfeld's study will be a decent piece of news. I'm really thinking R/S by the end of the year, so yes it's a game of hot potato, just like EVERY pinkie stinkie.

[Probity]

“under kelly's stewardship Biel trades daily between .0001-.0002.
which is where it will stick until the plug is pulled.
when that is is a matter of pure conjecture.”

Actually, you offer 2 “pure conjectures”, not just one. You know nothing of what will happen, or that “it” will indeed happen. Stop the nonsense.

“if a CEO has years in which to improve a company's prospects and has failed to do it,
why would anyone think something unprecedented will occur?”

Because some conjecture with broad-based reasoning.

For example, something unprecedented may happen if any CEO of an established company in the Pain Space sees that BIEL’s products can appreciably boost their bottom line given the upcoming NOPAIN Act and CMS insurance reimbursement. Leverage then shifts to BIEL’s favor for any negotiations in process, and exponentially so if more than one “outsider” is interested concurrently.

Here’s a broad-minded conjecture…
Should any company want BIEL’s products given the NPA/CMS…they already have the financial means and adequate personnel with varied specialties to get it done, a strong and politically savvy focus in place, dependable and long-standing established business connections to assist, and with access to and the monies for hiring the advertising movers and shakers to reach the medical establishments and whomever…boots on the ground.

Since you don’t diss BIEL’s products, I’ll conjecture you might now entertain that BIEL’s products’ might be of inherent value and a potential money-maker for “outsiders” given the Congressionally passed Act and CMS mandate? Or maybe that’s too much of a stretch?

imo